A Clinical Study Evaluating the Safety, Tolerability, Preliminary Efficacy and Immunogenicity of a Tumor Vaccine Injection Targeting Stressinducible Proteins MICA/B in Combination With the AG Regimen in Patients With Metastatic Pancreatic Cancer
Clinical trial NCT07231094 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07231094
- Sponsor
- The Third Xiangya Hospital of Central South University
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-01
- Primary completion
- 2027-11-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.